Thyroid eye disease: Redefining its management—A review

Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints....

Full description

Saved in:
Bibliographic Details
Main Authors: Amy P. Jain, Pimkwan Jaru-Ampornpan, Raymond S. Douglas
Other Authors: Siriraj Hospital
Format: Review
Published: 2022
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/78407
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Description
Summary:Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints. Teprotumumab offers an early, safe therapeutic intervention to help reverse disease end points such as diplopia and proptosis and improve quality of life.